The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Melanin content in melanoma metastases affects the outcome of radiotherapy
Open accessAbstract
// Anna A. Brożyna 1, 2 , Wojciech Jóźwicki 1, 2 , Krzysztof Roszkowski 3 , Jan Filipiak 4 , Andrzej T. Slominski 5, 6 1 Department of Tumour Pathology and Pathomorphology, Oncology Centre-Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland 2 Department of Tumour Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland 3 Department of Oncology, Radiotherapy and Gynecologic Oncology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland 4 Department of Chemotherapy, Oncology Centre-Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland 5 Departments of Dermatology and Pathology, University of Alabama at Birmingham, Birmingham, AL, USA 6 Laboratory Service of the VA Medical Center at Birmingham, Birmingham, AL, USA Correspondence to: Anna A. Brożyna, e-mail: anna.brozyna@cm.umk.pl Andrzej Slominski, e-mail: aslominski@uabmc.edu Keywords: melanoma, melanin, survival, radiotherapy Received: January 14, 2016 Accepted: February 11, 2016 Published: February 20, 2016 ABSTRACT Melanin possess radioprotective and scavenging properties, and its presence can affect the behavior of melanoma cells, its surrounding environment and susceptibility to the therapy, as showed in vitro experiments. To determine whether melanin presence in melanoma affects the efficiency of radiotherapy (RTH) we evaluated the survival time after RTH treatment in metastatic melanoma patients ( n = 57). In another cohort of melanoma patients ( n = 84), the relationship between melanin level and pT and pN status was determined. A significantly longer survival time was found in patients with amelanotic metastatic melanomas in comparison to the melanotic ones, who were treated with either RTH or chemotherapy (CHTH) and RTH. These differences were more significant in a group of melanoma patients treated only with RTH. A detailed analysis of primary melanomas revealed that melanin levels were significantly higher in melanoma cells invading reticular dermis than the papillary dermis. A significant reduction of melanin pigmentation in pT3 and pT4 melanomas in comparison to pT1 and T2 tumors was observed. However, melanin levels measured in pT3-pT4 melanomas developing metastases (pN1-3, pM1) were higher than in pN0 and pM0 cases. The presence of melanin in metastatic melanoma cells decreases the outcome of radiotherapy, and melanin synthesis is related to higher disease advancement. Based on our previous cell-based and clinical research and present research we also suggest that inhibition of melanogenesis can improve radiotherapy modalities. The mechanism of relationship between melanogenesis and efficacy of RTH requires additional studies, including larger melanoma patients population and orthotopic, imageable mouse models of metastatic melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The physical and chemical properties of eumelanin
Meredith, P., & Sarna, T. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00345.x · Cited by 1,033
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Brożyna, A. A., Jóźwicki, W., Carlson, J. A., & Slominski, A. T. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.02.022 · Cited by 175
Self-citationJanjetovic, Z., Brozyna, A. A., Tuckey, R. C., Kim, T.-K., Nguyen, M. N., Jozwicki, W., Pfeffer, S. R., Pfeffer, L. M., & Slominski, A. T. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.458 · Cited by 91
Self-citation
Cited by
Signaling Pathways in Melanogenesis
D’Mello, S., Finlay, G., Baguley, B., & Askarian-Amiri, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071144 · Cited by 1,071
Polydopamine free radical scavengers
Hu, J., Yang, L., Yang, P., Jiang, S., Liu, X., & Li, Y. (2020) · Biomaterials Science · doi:10.1039/d0bm01070g · Cited by 287
Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
Slominski, A. T., Hardeland, R., Zmijewski, M. A., Slominski, R. M., Reiter, R. J., & Paus, R. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.025 · Cited by 286
Self-citationMelanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship
Slominski, R. M., Sarna, T., Płonka, P. M., Raman, C., Brożyna, A. A., & Slominski, A. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.842496 · Cited by 286
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citation
Metadata
- Authors
- Brożyna, A. A., Jóźwicki, W., Roszkowski, K., Filipiak, J., & Slominski, A. T.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-02-20
- Volume
- 7
- Issue
- 14
- Pages
- 17844-17853
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2278568674
- Cited by
- 208
- References
- 3
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.